Artificial Intelligence Chatbots as an Educational Tool for Statistical Analysis Among Dental Students

July 2, 2026 updated by: Rowan Elshabrawy

Usability and Efficacy of Artificial Intelligence Chatbots as an Educational Aid for Statistical Data Analysis Among Dental Students: A Randomized Crossover Trial

The goal of this randomized crossover trial is to learn if ChatGPT-5.2 is usable and effective as a supplementary educational tool for teaching statistical data analysis to fifth-year undergraduate dental students. The study will also compare ChatGPT-5.2 with conventional statistical tools, such as Microsoft Excel and online statistical calculators.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Alexandria, Egypt
        • Faculty of dentistry, Alexandria university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Fifth-year undergraduate dental students enrolled at the Faculty of Dentistry, Alexandria University, Egypt.
  2. Students officially registered in the Research Project course (211082502) during the Spring 2026 semester.
  3. Provided written informed consent and agreed to participate voluntarily in the study.

Exclusion Criteria:

  1. Postgraduate students and undergraduate students not enrolled in the fifth year of the dental program, Faculty of Dentistry, Alexandria University, Egypt.
  2. Students not registered in the Research Project course during the Spring 2026 semester.

  3. Students who decline to provide written informed consent to participate in the study

    -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Group A will solve the first assignment using ChatGPT, and the second using conventional methods
Other: ChatGPT 5.2
ChatGPT 5.2 will be used for solving the statistical analysis assignment
Other: Conventional methods
Microsoft excel and online calculators will be used to solve the statistical analysis assignment
Experimental: Group B
Group A will solve the first assignment using ChatGPT, and the second using conventional methods
Other: ChatGPT 5.2
ChatGPT 5.2 will be used for solving the statistical analysis assignment
Other: Conventional methods
Microsoft excel and online calculators will be used to solve the statistical analysis assignment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The efficacy of technological tools for completing the statistical analysis assignments.
Time Frame: 21 days

Efficacy will be evaluated by comparing participants' performance scores across the two tools (AI-ChatGPT-5.2 and conventional tools). Scores will be calculated as the percentage of correct answers in the two assignments.

Score = (Number of correct answers)/(total number of questions)×100
21 days
The usability of the technological tools for completing the statistical analysis assignments
Time Frame: 21 days

Usability is defined as "the extent to which a product can be used by specified users to achieve specific goals with effectiveness, efficiency, and satisfaction in a specified context of use. it will be assessed using system usability questionnaire(SUS), SUS yields a single number representing a composite measure of the overall usability of the system being studied. Note that scores for individual items are not meaningful on their own.

To calculate the SUS score, first sum the score contributions from each item. Each item's score contribution will range from 0 to 4. For items 1,3,5,7,and 9 the score contribution is the scale position minus 1. For items 2,4,6,8 and 10, the contribution is 5 minus the scale position. Multiply the sum of the scores by 2.5 to obtain the overall value of SU.

SUS scores have a range of 0 to 100.
21 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rowan Elshabrawy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2026

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

June 29, 2026

First Submitted That Met QC Criteria

July 2, 2026

First Posted (Actual)

July 6, 2026

Study Record Updates

Last Update Posted (Actual)

July 6, 2026

Last Update Submitted That Met QC Criteria

July 2, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB No: 00010556-IORG: 0008839

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe